Interpretable Prediction Model for Short-Term and Long-Term Hepatic Encephalopathy and Variceal Rebleeding After Transjugular Intrahepatic Portosystemic Shunt: A Real-World Study
Open Access
- 18 September 2026
- journal article
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
Abstract
INTRODUCTION: Transjugular intrahepatic portosystemic shunt (TIPS) relieves portal hypertension, but post-TIPS overt hepatic encephalopathy (OHE) and variceal rebleeding (VRB) remain outcomes that significantly impair survival. The aim of this study was to identify risk factors and develop an interpretable machine learning model predicting 2-year and 6-year OHE and VRB. METHODS: In this multicenter retrospective study, 636 patients undergoing TIPS (2014–2023) with 2–6 years follow-up were analyzed. A detailed perioperative data set was curated. Least Absolute Shrinkage and Selection Operator selected key predictors for model training in an integrated machine learning voting ensemble (ML-VE) framework. Efficacy was assessed by area under the receiver operating characteristic curve (AUC) and compared with conventional clinical scores (Child-Pugh, MELD, and MELD-Na). Subgroup analyses were conducted, and Shapley Additive Explanations were used for interpretation. RESULTS: The cumulative incidences of OHE and VRB were 22.2% and 8.2% at 2 years, respectively, increasing to 24.8% and 10.1% at 6 years. Internally, ML-VE achieved AUCs of 0.960 (OHE) and 0.966 (VRB) at 2 years and 0.849 (OHE) and 0.828 (VRB) at 6 years. External validation for OHE yielded AUCs of 0.914 at 2 years and 0.924 at 6 years, outperforming conventional scores (AUC 0.528–0.563 for OHE; 0.528–0.555 for VRB). All prespecified subgroups had 2-year AUCs ≥0.93 (OHE prediction in portal vein thrombosis: 0.993; VRB prediction in portal pressure gradient 9–12 mm Hg: 0.987). SHapley Additive exPlanationsidentified “diabetes” as the strongest predictor of OHE and “recent bleeding” as the strongest predictor of VRB at 2 years. DISCUSSION: The interpretable ML-VE model showed good discrimination for 2-year and 6-year post-TIPS OHE and VRB risk, suggesting potential utility for short-term and long-term risk stratification after TIPS.Keywords
Funding Information
- National Health Commission Capacity Building and Continuing Education Center (YXFSC2022JJSJ007)
- National Natural Science Foundation of China (82502307)
- the Postdoctoral Fellowship Program of CPSF (GZC20241147)
- China Postdoctoral Science Foundation (2024M752252)
This publication has 28 references indexed in Scilit:
- Early Occurrence of Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt Insertion is Linked to Impaired Survival: A Multicenter Cohort StudyClinical Gastroenterology and Hepatology, 2025
- Development and validation of a machine learning-based model to predict survival in patients with cirrhosis after transjugular intrahepatic portosystemic shunteClinicalMedicine, 2024
- Diabetes mellitus – risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?Metabolic Brain Disease, 2022
- EASL Clinical Practice Guidelines on the management of hepatic encephalopathyJournal of Hepatology, 2022
- Baveno VII – Renewing consensus in portal hypertensionJournal of Hepatology, 2022
- Portal hypertensive bleeding in cirrhosisHepatology, 2017
- Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver DiseasesJournal of Hepatology, 2014
- Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the LiverHepatology, 2014
- Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: Results in 90 patientsGastroenterology, 1995
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973